Raslan M, Mercader C, Lamb AD. Re: Prostate Cancer Screening Using a Combination of Risk-prediction, MRI, and Targeted Prostate Biopsies (STHLM3-MRI): A Prospective, Population-based, Randomised, Open-label, Non-inferiority Trial. Eur Urol 2022 Jan 29. pii: S0302-2838(22)00021.
PMID: 35105477